Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
Marta Ruíz-Ortega, Raúl R. Rodrigues-Díez, Carolina Lavoz, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 813-813
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease
Guoqing Huang, Mingcai Li, Yan Li, et al.
Laboratory Medicine (2022) Vol. 53, Iss. 6, pp. 545-551
Closed Access | Times Cited: 863
GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis
Rui Shen, Songyan Qin, Yunhui Lv, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 4, pp. 167060-167060
Closed Access | Times Cited: 15
New progress in drugs treatment of diabetic kidney disease
Junmin Wang, Hongjiao Xiang, Yifei Lü, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111918-111918
Open Access | Times Cited: 56
Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20–59 years, 1990–2019
Dandan Xie, Tianpeng Ma, Haoliang Cui, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Insulin Requirement Profiles of Short‐Term Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 2 Diabetic Nephropathy
Qingliang Feng, B.B. Li, Jiating Lin, et al.
International Journal of Endocrinology (2025) Vol. 2025, Iss. 1
Open Access | Times Cited: 1
EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress
Roberta Giordo, Yusra M. A. Ahmed, Hilda Allam, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48
Stabilized-chitosan selenium nanoparticles efficiently reduce renal tissue injury and regulate the expression pattern of aldose reductase in the diabetic-nephropathy rat model
Safaa I. Khater, Amany Abdel-Rahman Mohamed, Ahmed Hamed Arisha, et al.
Life Sciences (2021) Vol. 279, pp. 119674-119674
Closed Access | Times Cited: 42
Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression
Junlin Zhang, Xiang Xiao, Yucheng Wu, et al.
Nutrients (2022) Vol. 14, Iss. 17, pp. 3634-3634
Open Access | Times Cited: 34
ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease
Junlin Zhang, Yucheng Wu, Jie Zhang, et al.
Metabolism (2022) Vol. 139, pp. 155377-155377
Closed Access | Times Cited: 34
Renoprotective Effects of Tanshinone IIA: A Literature Review
Zhengtao Chen, Haoyue Feng, Chuan Peng, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1990-1990
Open Access | Times Cited: 19
Identification of diagnostic markers related to oxidative stress and inflammatory response in diabetic kidney disease by machine learning algorithms: Evidence from human transcriptomic data and mouse experiments
Ming Zhong, Enyi Zhu, Na Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis
Lili Zhang, Runyu Miao, Tongyue Yu, et al.
Pharmacological Research (2022) Vol. 177, pp. 106111-106111
Closed Access | Times Cited: 23
p-Coumaric Acid Nanoparticles Ameliorate Diabetic Nephropathy via Regulating mRNA Expression of KIM-1 and GLUT-2 in Streptozotocin-Induced Diabetic Rats
Amalan Venkatesan, Anitha Roy, Srinivasan Kulandaivel, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1166-1166
Open Access | Times Cited: 22
Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway
Jian Lü, Xueqi Li, Peipei Chen, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 2, pp. 366-377
Closed Access | Times Cited: 15
The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease
Leipengyun Deng, Chunru Shi, Run Li, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118424-118424
Closed Access | Times Cited: 5
New insights in the treatment of DKD: recent advances and future prospects
Meimei Zhao, Yongtong Cao, Liang Ma
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Flavonoids from Coreopsis tinctoria Nutt alleviate renal injuries in db/db mice models through the AGE/RAGE pathway
Limin Guo, Yina Meng, Haijing Zhang, et al.
Noordanesh. (2025) Vol. 20, Iss. 02
Closed Access
Systematic Evaluation and Meta-analysis of Traditional Chinese Medicine in the Treatment of Diabetic Nephropathy
Xu Huang, Dongxue Chen, Shuxuan Wang, et al.
Applied Mathematics and Nonlinear Sciences (2025) Vol. 10, Iss. 1
Open Access
Study of the relationship between the level of pro-inflammatory cytokines and β2-microglobulin with indicators of changes in the functional status of the kidneys in diabetic nepropathy to determine the degrees of chronic renal failure
R. V. Alekseienko, V.D. Markovskiy, Liubov Rysovana, et al.
Wiadomości Lekarskie (2025), Iss. 2, pp. 248-256
Closed Access
Role of gasdermins in chronic kidney disease
Hanchao Gao, Ting Xie, Yunyi Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Single-nucleus RNA sequencing reveals ARHGAP28 expression of podocytes as a biomarker in human diabetic nephropathy
Fengxia Zhang, Xianhu Tang, Zhimei Zeng, et al.
Open Medicine (2025) Vol. 20, Iss. 1
Open Access
Patterns of Toll-Like Receptor Expressions and Inflammatory Cytokine Levels and Their Implications in the Progress of Insulin Resistance and Diabetic Nephropathy in Type 2 Diabetic Patients
Rofyda H. Aly, Amr E. Ahmed, Walaa G. Hozayen, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 36
Ferroptosis and Traditional Chinese Medicine for Type 2 Diabetes Mellitus
Dandan Xie, Kai Li, R. Feng, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1915-1930
Open Access | Times Cited: 11
Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy
Maoying Wei, Xingxing Liu, Zhijuan Tan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
The Severity of Diabetic Retinopathy Is an Independent Factor for the Progression of Diabetic Nephropathy
Shi-Chue Hsing, Chia‐Cheng Lee, Chin Lin, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 3-3
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top